Wagenlehner Florian M E, Schneider H, Weidner W
Klinik und Poliklinik für Urologie und Kinderurologie, Justus-Liebig-Universität Giessen.
Urologe A. 2007 Feb;46(2):W185-96; quiz W197. doi: 10.1007/s00120-006-1275-4.
Prostatitis syndrome is a multifactorial disease with a largely unknown etiology. Quite different therapeutic options are therefore recommended. According to the new NIH classification, pathogens can be cultured only in acute and chronic bacterial prostatitis. A long-term antimicrobial therapy, mainly with fluoroquinolones, is then recommended. Most patients suffer from chronic pelvic pain syndrome (CP/CPPS) which can be subdivided into inflammatory and non-inflammatory types. Whether the inflammatory CP/CPPS is an infectious disease remains uncertain. The effect of an antibiotic therapy therefore remains debatable. In case of proven or suspected functional infravesical obstruction, treatment with a-receptor blockers is recommended. Accompanying symptomatic therapy is also recommended. It is important, however, to keep the patient fully informed about the diagnostic and therapeutic limitations.
前列腺炎综合征是一种病因大多不明的多因素疾病。因此，推荐了截然不同的治疗方案。根据美国国立卫生研究院（NIH）的新分类，仅在急性和慢性细菌性前列腺炎中可培养出病原体。随后推荐进行长期抗菌治疗，主要使用氟喹诺酮类药物。大多数患者患有慢性盆腔疼痛综合征（CP/CPPS），该综合征可细分为炎症性和非炎症性类型。炎症性CP/CPPS是否为传染病仍不确定。因此，抗生素治疗的效果仍存在争议。如果证实或怀疑存在功能性膀胱颈梗阻，推荐使用α受体阻滞剂进行治疗。也推荐进行对症治疗。然而，让患者充分了解诊断和治疗的局限性很重要。
